AI Science Tracker
EN

Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data.

Affiliation not stated in the reviewed material · 28 Jul 2020 · medicine

Discovery

Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Institutional repository copy of the primary eLife manuscript supplies Methods/Results for NK-cell flow-cytometry features and model evaluation in asymptomatic and clinical cohorts; the result is a small-cohort classification proof of concept.

Technology: Machine-learning models classify prostate-cancer status and clinical risk from peripheral natural-killer-cell phenotyping.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning models classify prostate-cancer status and clinical risk from peripheral natural-killer-cell phenotyping.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://irep.ntu.ac.uk/id/eprint/40312/1/1349937_Pockley.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.